[go: up one dir, main page]

MX2013007675A - Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa. - Google Patents

Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa.

Info

Publication number
MX2013007675A
MX2013007675A MX2013007675A MX2013007675A MX2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A
Authority
MX
Mexico
Prior art keywords
human milk
milk oligosaccharides
probiotic
promote growth
beneficial microbiota
Prior art date
Application number
MX2013007675A
Other languages
English (en)
Other versions
MX356184B (es
Inventor
Jomay Chow
Rachael Buck
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2013007675A publication Critical patent/MX2013007675A/es
Publication of MX356184B publication Critical patent/MX356184B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describen las composiciones nutricionales que incluyen los oligosacáridos de leche humana que se pueden administrar a los individuos, que incluyen bebés prematuros, bebés, infantes y niños, para mejorar la función y la tolerancia gastrointestinales, así como el crecimiento de la microbiota beneficiosa. También se describen los métodos adicionales convenientes para usar las composiciones nutricionales que incluyen los oligosacáridos de leche humana.
MX2013007675A 2010-12-31 2011-12-22 Fórmulación pediátrica sintética que comprende un probiótico. MX356184B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428869P 2010-12-31 2010-12-31
PCT/US2011/067012 WO2012092155A1 (en) 2010-12-31 2011-12-22 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota

Publications (2)

Publication Number Publication Date
MX2013007675A true MX2013007675A (es) 2013-07-29
MX356184B MX356184B (es) 2018-05-17

Family

ID=45529204

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007675A MX356184B (es) 2010-12-31 2011-12-22 Fórmulación pediátrica sintética que comprende un probiótico.

Country Status (12)

Country Link
US (1) US20120171166A1 (es)
EP (2) EP2658402A1 (es)
CN (1) CN103763940B (es)
BR (1) BR112013016914A2 (es)
CA (1) CA2822660C (es)
HK (1) HK1256876A1 (es)
MX (1) MX356184B (es)
NZ (1) NZ612386A (es)
PH (1) PH12013501291A1 (es)
SG (1) SG191798A1 (es)
TW (1) TW201304692A (es)
WO (1) WO2012092155A1 (es)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2506725B1 (en) 2010-12-29 2016-05-04 Abbott Laboratories Nutritional products including monoglycerides and fatty acids
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
SG191393A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
AU2012215042B2 (en) * 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY169326A (en) 2011-08-29 2019-03-21 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2708145B1 (en) 2012-09-14 2016-05-04 Abbott Laboratories Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
DK2708147T3 (da) * 2012-09-14 2020-05-18 Abbott Lab Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
CA2897363C (en) 2013-01-21 2016-06-21 Universitat Zurich Baby food composition comprising viable propionic acid-producing bacteria
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CA2901469A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc. Rice protein supplements
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
EP3082473A2 (en) * 2013-12-19 2016-10-26 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
WO2015157098A1 (en) * 2014-04-08 2015-10-15 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
CN114376234A (zh) 2014-10-24 2022-04-22 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
JP7182872B2 (ja) 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法
ES2856053T3 (es) * 2014-10-29 2021-09-27 Glycom As Composición sintética y procedimiento para promover la cicatrización de la mucosa
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US10828313B2 (en) * 2014-12-08 2020-11-10 Glycom A/S Synthetic composition for treating metabolic disorders
CN104528149A (zh) * 2014-12-31 2015-04-22 福建美力生生物科技股份有限公司 一种即用型益生菌饮料产品
MX385961B (es) * 2015-01-14 2025-03-18 Infant Bacterial Therapeutics Ab Un método para la activación de bacterias de ácido láctico.
PH12017550044B1 (en) 2015-03-05 2022-04-27 Socia‰Ta‰ Des Produits Nestla‰ S A Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
RU2758856C2 (ru) * 2015-08-04 2021-11-02 Сосьете Де Продюи Нестле С.А. Питательные композиции и детские смеси, включающие bifidobacterium animalis подвида lactis и необязательно смесь олигосахаридов, для индукции кишечной микробиоты, которая похожа на микробиоту младенцев, находящихся на грудном вскармливании
MX379149B (es) * 2015-08-04 2025-03-10 Soc Des Produits Nestle S A Star Composiciones nutricionales con 2fl y lnnt para usar en la inducción de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.
ES2886951T3 (es) * 2015-09-14 2021-12-21 Glycom As Composición para su uso en la modulación de la microbiota
US10780103B2 (en) * 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
AU2017213082B2 (en) * 2016-01-26 2021-07-01 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
WO2017129642A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Composition for use in the prevention and/or treatment of skin conditions and skin diseases
MX382373B (es) * 2016-01-26 2025-03-13 Soc Des Produits Nestle S A Star Oligosacáridos de la leche humana para beneficios de la salud mediante la prevención del rebote adiposo precoz.
AU2017211270B2 (en) * 2016-01-26 2022-12-08 Société des Produits Nestlé S.A. Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
EP3407741A1 (en) 2016-01-26 2018-12-05 Nestec S.A. Compositions with specific oligosaccharides to prevent or treat allergies
AU2017230187A1 (en) * 2016-03-11 2018-10-04 Infinant Health, Inc A transient commensal microorganism for improving gut health
PL3452050T3 (pl) * 2016-05-05 2023-06-12 Glycom A/S Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
EP3458073B1 (en) * 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
AU2017275210B2 (en) * 2016-05-31 2020-09-10 Morinaga Milk Industry Co., Ltd. Brain function improving agent
US20220233561A1 (en) * 2016-06-05 2022-07-28 Glycom A/S Human milk oligosaccharides for use in the treatment of symptoms in a patient suffering from non-coeliac wheat and / or gluten sensitivity
CA3029631A1 (en) * 2016-07-01 2018-01-04 Evolve Biosystems, Inc. Method for facilitating maturation of the mammalian immune system
ES2992190T3 (es) * 2016-08-04 2024-12-10 Nestle Sa Composiciones nutritivas y fórmulas infantiles que comprenden una mezcla de oligosacáridos y, opcionalmente, Bifidobacterium lactis para prevenir, tratar o reducir la gravedad de la diarrea asociada a no rotavirus
US20180064739A1 (en) * 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180133287A1 (en) * 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
WO2018118558A1 (en) * 2016-12-19 2018-06-28 Aly Hany Z Medical-grade honey for growth enhancement of infants
US11253530B2 (en) 2017-05-09 2022-02-22 Societe Des Produits Nestle S.A. Synergistic production of butyrate associated with the complexity of HMOS blend for use in infants or young children for health purposes
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
EP3629768A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
EP3691658A4 (en) * 2017-10-04 2021-06-23 The Regents of The University of California IMMUNOMODULATOR OLIGOSACCHARIDES
EP3703698A4 (en) * 2017-11-02 2021-08-18 Glycom A/S ONE OR MORE HMOS TO REDUCE OR PREVENT FATIGUE AND / OR IMPROVE FOCUS OR CONCENTRATION
JP2021504420A (ja) * 2017-11-30 2021-02-15 グリコム・アクティーゼルスカブＧｌｙｃｏｍ Ａ／Ｓ 微生物叢調節のためのヒトミルクオリゴ糖およびその合成組成物
JP7327724B2 (ja) * 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ 小麦過敏症を処置するためのｈｍｏの混合物
MX2020007192A (es) 2017-12-01 2020-08-24 Nestle Sa Composicion fortificadora de leche humana.
BR112020011242A2 (pt) * 2017-12-08 2020-11-17 Jennewein Biotechnologie Gmbh mistura seca por pulverização de oligossacarídeos de leite humano
AU2018387291B2 (en) * 2017-12-21 2024-10-10 Societe Des Produits Nestle S.A. Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility
JP7280243B2 (ja) * 2018-03-29 2023-05-23 森永乳業株式会社 栄養組成物並びに該栄養組成物を用いた飲食品組成物及び調製粉乳
EP3583858A1 (en) * 2018-06-20 2019-12-25 DuPont Nutrition Biosciences ApS Compositions for treating or preventing gut barrier dysfunction
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
EP3801557A4 (en) * 2018-05-30 2022-03-09 Evolve Biosystems Inc. COMPOSITIONS AND METHOD OF USE FOR BIFIDOBACTERIUM LONGUM SUBSP. COMPETENT FOR H5
SG11202011817WA (en) * 2018-06-01 2020-12-30 Evolve Biosystems Inc Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
BR112020023102A2 (pt) * 2018-06-25 2021-02-02 Société des Produits Nestlé S.A. uso de oligossacarídeos de leite humano, e composição que compreende os mesmos
WO2020013683A1 (en) 2018-07-12 2020-01-16 N.V. Nutricia Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
EP3897662B1 (en) 2018-12-19 2024-07-24 Glycom A/S Composition comprising a human milk oligosaccharide for use in treating humans using low-fodmap diets
US20220054514A1 (en) * 2018-12-20 2022-02-24 Société des Produits Nestlé S.A. Human milk fortifier composition
AU2019407123B2 (en) 2018-12-21 2025-04-10 Societe Des Produits Nestle S.A. A nutritional composition comprising 6'SL and LNT in combination to improve the gastrointestinal barrier function
EP3897663A4 (en) * 2018-12-21 2022-09-07 Glycom A/S COMPOSITION AND METHOD FOR PROMOTING HEALING OF THE INTESTINAL BARRIER
US20220225627A1 (en) * 2019-03-05 2022-07-21 Societe Des Produits Nestle S.A. A nutritional composition for use to enhance executive function
BR112021016924A2 (pt) * 2019-03-05 2021-11-03 Glycom As Oligossacarídeos do leite humano para uso no aprimoramento da função executiva
CN114072013A (zh) * 2019-05-29 2022-02-18 N·V·努特里奇亚 用于降低结肠蛋白发酵的非消化性寡糖
HUE063680T2 (hu) * 2019-06-04 2024-01-28 Nutricia Nv 2'-fukozillaktózt és 3'-galaktozillaktózt tartalmazó táplálkozási készítmény
IL293174A (en) * 2019-11-20 2022-07-01 Abbott Lab Nutritional compositions for treating a clostridium difficile infection
CN112869168B (zh) * 2019-11-29 2023-06-06 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
JP2023508846A (ja) * 2019-12-30 2023-03-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳児用フォーミュラ
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
JP7516053B2 (ja) * 2020-01-20 2024-07-16 森永乳業株式会社 組成物並びに飲食品組成物、栄養組成物および調製乳
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
EP4243634A1 (en) * 2020-11-10 2023-09-20 Société des Produits Nestlé S.A. Nutritional composition
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
EP4255220A1 (en) * 2020-12-01 2023-10-11 FrieslandCampina Nederland B.V. 2'-fucosyllactose for use in stimulating f. prausnitzii abundance
CN116615117A (zh) * 2020-12-01 2023-08-18 菲仕兰坎皮纳荷兰公司 用于刺激普氏栖粪杆菌丰度的2’-岩藻糖基乳糖
EP4277634A1 (en) * 2021-01-12 2023-11-22 Prolacta Bioscience, Inc. Synbiotic treatment regimens
CN113796546A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 改善肠道屏障功能母乳低聚糖组合物及其应用
CN114223728B (zh) * 2021-11-30 2024-03-26 内蒙古伊利实业集团股份有限公司 含有益生元与益生菌的早产/低出生体重婴儿配方奶粉
WO2024184259A1 (en) * 2023-03-03 2024-09-12 Chr. Hansen A/S Composition comprising bifidobacterium animalis subsp. lactis strain and 2'-fucosyllactose
WO2024184260A2 (en) * 2023-03-03 2024-09-12 Chr. Hansen A/S Composition comprising bifidobacterium longum subsp. infantis, bifidobacterium breve and 2'-fucosyllactose
WO2024209522A1 (en) * 2023-04-03 2024-10-10 Morinaga Milk Industry Co., Ltd. Bifidobacterium for reducing perilipin 4 expression
WO2024218196A1 (en) * 2023-04-19 2024-10-24 Chr. Hansen A/S 3-fucosyllactose
WO2025132299A1 (en) * 2023-12-19 2025-06-26 Société des Produits Nestlé S.A. Compositions for preventing or treating atopic disease and/or respiratory infection

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2199317C2 (ru) 1997-02-21 2003-02-27 Абботт Лаборэтриз Способ снижения заболеваемости некротическим энтероколитом у детей (варианты)
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
BRPI0108478B8 (pt) * 2000-02-17 2021-05-25 Nestec Sa composição nutritiva contendo substancias pré-bióticas
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
ES2416287T3 (es) * 2003-06-23 2013-07-31 Nestec S.A. Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007101675A1 (en) * 2006-03-07 2007-09-13 Nestec S.A. Synbiotic mixture
MY191118A (en) * 2006-03-10 2022-05-30 Nutricia Nv Use of non-digestible saccharides for giving an infant the best start after birth
US20070255598A1 (en) * 2006-03-29 2007-11-01 Mccarthy Nancy J Compliance aid, kits comprising the compliance aid, and methods of use
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
JP5766947B2 (ja) * 2007-09-07 2015-08-19 チルドレンズ ホスピタル メディカル センター 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2127661A1 (en) * 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
BR112012017978A2 (pt) * 2010-01-19 2016-05-03 Abbott Lab fórmulas nutricionais contendo simbióticos

Also Published As

Publication number Publication date
CA2822660C (en) 2021-09-07
US20120171166A1 (en) 2012-07-05
CN103763940A (zh) 2014-04-30
EP3335577A1 (en) 2018-06-20
CN103763940B (zh) 2015-10-14
SG191798A1 (en) 2013-08-30
NZ612386A (en) 2015-02-27
CA2822660A1 (en) 2012-07-05
HK1256876A1 (en) 2019-10-04
EP2658402A1 (en) 2013-11-06
WO2012092155A1 (en) 2012-07-05
BR112013016914A2 (pt) 2019-09-24
PH12013501291A1 (en) 2013-09-09
TW201304692A (zh) 2013-02-01
MX356184B (es) 2018-05-17

Similar Documents

Publication Publication Date Title
MX2013007675A (es) Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa.
BR112013016929A2 (pt) oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
MX388089B (es) Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
ES2527200T3 (es) Modulación del crecimiento de las bífidobacterias mediante una combinación de oligosacáridos de la leche humana
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MX376863B (es) Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
IN2015DN03862A (es)
PH12013501387A1 (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MY186188A (en) Nutritional phytonutrient compositions
BR112014001472A2 (pt) galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
MX2010004120A (es) Metodos para mantener o incrementar el crecimiento o desarrollo cognitivo.
MX340953B (es) Anticuerpos anti receptor del factor de necrosis tumoral inducido por glucocorticoides.
CL2016001454A1 (es) Composiciones sintéticas de leche para el crecimiento y desarrollo óptimos y prevención de la obesidad en infantes y niños varones y femeninas
AR094624A1 (es) Gestión de la dieta para enfermedad celíaca y alergia a los alimentos
MX367035B (es) Composiciones para el cuidado bucal que contienen particulas biodegradables con estetica superior.
PH12013501388A1 (en) Methods of using human milk oligosaccharides for improving airway respiratory health
MX384125B (es) Composiciones sintéticas de leche para infantes menores que tres meses de edad y para infantes y niños mayores que tres meses para asegurar el crecimiento óptimo y prevenir la obesidad.

Legal Events

Date Code Title Description
FG Grant or registration